Psychiatric Comorbidity Reduces Quality of Life in Chronic Methadone Maintained Patients
The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
Despite the efficacy of methadone maintenance treatment (MMT), opioid dependence still involves severe impairment offunctioning and low quality of life. This study examines the influence of the psychiatric comorbidity of MMT patients on their quality of life. A total of 193 middle‐aged patients in long‐term MMT were assessed for current and lifetime Axis I psychiatric disorders, substance use disorders, and personality disorders using the MINI, the CIDI‐SAM, and the SIDP‐IV. Quality of life (Qol) was assessed using the EQ‐5D. Psychiatric comorbidity was documented in 78% of the patients. Mood disorders (60%) and anxiety disorders (46%) were the most common diagnoses. Additional substance use disorders were diagnosed in 70% of the MMT patients. While a probable personality disorder was documented for 65% of the patients, 66 of these patients actually showed an antisocial personality disorder. Qol was severely diminished to a level comparable to that for patients with chronic psychiatric and/or somatic disorders. Multivariate analyses showed the occurrence of comorbid psychiatric disorders to explain about 32% of the variance in Qol. The quality of life for MMT patients is generally low. The present results showed a high rate of psychiatric comorbidity for this patient group with mood disorders, additional substance use disorders, and personality disorders occurring in particular. Such comorbid psychopathology substantially affects quality of life. The negative influence of comorbid psychopathology on quality of life is an important reason to provide additional mental health services for MMT patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“relapse for SUD, experience increased distress, internalized stigma, lower quality of life, and a higher likelihood of using multiple substances than people diagnosed with SUD alone(Carpentier et al., 2009; Chang et al., 2019; Conway et al., 2006; Lejuez et al., 2008; Rogers et al., 2019).”
From A systematic review and meta-analysis of psychosocial interventions for persons with comorbid anxiety and substance use disorders (2024) · cites this paper as Carpentier et al., 2009
Citations
Cites
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
The mini international neuropsychiatric interview
Lecrubier, Y., Sheehan, D., Hergueta, T., & Weiller, E. (1998) · European Psychiatry · doi:10.1016/s0924-9338(99)80239-9 · Cited by 5,872
EuroQol: the current state of play
Brooks, R. (1996) · Health Policy · doi:10.1016/0168-8510(96)00822-6 · Cited by 5,815
(1997) · doi:10.1097/00005650-199711000-00002 · Cited by 4,544
McLELLAN, A. T., LUBORSKY, L., WOODY, G. E., & O??BRIEN, C. P. (1980) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198001000-00006 · Cited by 3,188
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654
A 33-Year Follow-up of Narcotics Addicts
Hser, Y.-I., Hoffman, V., Grella, C. E., & Anglin, M. D. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.503 · Cited by 848
Psychiatric and Substance Use Comorbidity Among Treatment-Seeking Opioid Abusers
Brooner, R. K. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830130077015 · Cited by 746
Mueser, K. T., Drake, R. E., & Wallach, M. A. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00073-2 · Cited by 617
The epidemiology of dual diagnosis
Kessler, R. C. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.034 · Cited by 588
Research works printed but not linked: 3
- Fischer B, 2001, Substitution: Zwischen Leben und Sterben, 21
- Pfohl B, Structured Interview for DSM‐IV Personality Disorders. 1‐9‐1997
- Szende A, 2008, Measuring self‐reported population health: an international perspective based on EQ‐5D
Cited by
Johansson, R., Carlbring, P., Heedman, Å., Paxling, B., & Andersson, G. (2013) · PeerJ · doi:10.7717/peerj.98 · Cited by 309
Maeyer, J. D., Vanderplasschen, W., Camfield, L., Vanheule, S., Sabbe, B., & Broekaert, E. (2011) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2011.03.009 · Cited by 179
Muller, A. E., Skurtveit, S. O., & Clausen, T. (2016) · Health and Quality of Life Outcomes · doi:10.1186/s12955-016-0439-1 · Cited by 127
De Maeyer, J., Vanderplasschen, W., Lammertyn, J., van Nieuwenhuizen, C., Sabbe, B., & Broekaert, E. (2011) · Quality of Life Research · doi:10.1007/s11136-010-9732-3 · Cited by 102
Alho, H., Demattéis, M., Lembo, D., Maremmani, I., Roncero, C., & Somaini, L. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.102616 · Cited by 100
Carpentier, P. J., van Gogh, M. T., Knapen, L. J. M., Buitelaar, J. K., & De Jong, C. A. J. (2011) · European Addiction Research · doi:10.1159/000321259 · Cited by 96
Self-citationRosic, T., Naji, L., Bawor, M., Dennis, B. B., Plater, C., Marsh, D. C., Thabane, L., & Samaan, Z. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s129480 · Cited by 95
White, W. L., Campbell, M. D., Spencer, R. D., Hoffman, H. A., Crissman, B., & DuPont, R. L. (2014) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2014.901587 · Cited by 86
Severity and Interference of Chronic Pain in Methadone-Maintained Outpatients
Dunn, K. E., Brooner, R. K., & Clark, M. R. (2014) · Pain Medicine · doi:10.1111/pme.12430 · Cited by 83
Roncero, C., Barral, C., Rodríguez-Cintas, L., Pérez-Pazos, J., Martínez‐Luna, N., Casas, M., Torrens, M., & Grau‐López, L. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.06.024 · Cited by 83
Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us?
Carpentier, P. J., & LEVIN, F. R. (2017) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000122 · Cited by 78
Self-citationLe, T. A., Le, M. Q. T., Dang, A. D., Dang, A. K., Nguyen, C. T., Pham, H. Q., Vu, G. T., Hoang, C. L., Tran, T. T., Vuong, Q.-H., et al. (2019) · Substance Abuse Treatment, Prevention, and Policy · doi:10.1186/s13011-019-0223-4 · Cited by 75
Zhu, Y., Mooney, L. J., Yoo, C. K., Evans, E., Kelleghan, A. R., Saxon, A. J., Curtis, M. E., & Hser, Y. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108996 · Cited by 74
Opioid use disorder and the brain: a clinical perspective
Herlinger, K., & Lingford-Hughes, A. R. (2021) · Addiction · doi:10.1111/add.15636 · Cited by 73
Yin, W., Pang, L., Cao, X., McGoogan, J. M., Liu, M., Zhang, C., Li, Z., Li, J., & Rou, K. (2014) · Addiction · doi:10.1111/add.12780 · Cited by 71
Lozano, O. M., Tejada, A. J. R., & Fernández‐Calderón, F. (2016) · Journal of Mental Health · doi:10.1080/09638237.2016.1177771 · Cited by 66
Brooner, R. K., KIDORF, M. S., King, V. L., Peirce, J. M., Neufeld, K. J., Stoller, K. B., & Kolodner, K. (2013) · Addiction · doi:10.1111/add.12269 · Cited by 63
Improvement of quality of life in methadone treatment patients in northern Taiwan: a follow-up study
Chou, Y.-C., Shih, S., Tsai, W. D., Li, C.-S. R., Xu, K., & Lee, T. S. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-190 · Cited by 61
Savant, J. D., Barry, D. T., Cutter, C. J., Joy, M. T., Dinh, A., Schottenfeld, R. S., & Fiellin, D. A. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.06.020 · Cited by 54
Teoh, J. B. F., Yee, A. H. A., & Habil, M. H. (2015) · American Journal on Addictions · doi:10.1111/ajad.12317 · Cited by 53
Stephen, J. H., Halpern, C. H., Barrios, C. J., Balmuri, U., Pisapia, J. M., Wolf, J. A., Kampman, K. M., Baltuch, G. H., Caplan, A. L., & Stein, S. C. (2012) · Addiction · doi:10.1111/j.1360-0443.2011.03656.x · Cited by 51
Trujols, J., López, I. G., Siñol, N., del Pozo, J., Portella, M. J., & Cobos, J. P. D. L. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.10.014 · Cited by 51
Chang, K.-C., Lin, C.-Y., Chang, C.-C., Ting, S.-Y., Cheng, C.-M., & Wang, J.-D. (2019) · PLOS ONE · doi:10.1371/journal.pone.0211033 · Cited by 50
Gyawali, B., Choulagai, B. P., Paneru, D. P., Ahmad, M., Leppin, A., & Kallestrup, P. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-1003-6 · Cited by 49
Acute effects of heroin on emotions in heroin‐dependent patients
Blum, J., Gerber, H., Gerhard, U., Schmid, O., Petitjean, S. A., Riecher‐Rössler, A., Wiesbeck, G. A., Borgwardt, S., & Walter, M. (2013) · American Journal on Addictions · doi:10.1111/j.1521-0391.2013.12025.x · Cited by 48
Carpentier, P. J., Vásquez, A. A., Hoogman, M., Onnink, A. M. H., Kan, C. C., Kooij, J. J. S., Makkinje, R. R., Iskandar, S., Kiemeney, L. A. L. M., de Jong, C. A. J., et al. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.07.003 · Cited by 48
Self-citationStrada, L., Schmidt, C. S., Rosenkranz, M., Verthein, U., Scherbaum, N., Reimer, J., & Schulte, B. (2019) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-018-0187-9 · Cited by 47
Ling, W., Nadipelli, V. R., Solem, C. T., Ronquest, N. A., Yeh, Y.-C., Learned, S. M., Mehra, V., & Heidbreder, C. (2019) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000517 · Cited by 46
Pedrelli, P., Iovieno, N., Vitali, M., Tedeschini, E., Bentley, K. H., & Papakostas, G. I. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31822c0adf · Cited by 46
Gender differences in Health Related Quality of Life of young heroin users.
Domingo‐Salvany, A., Brugal, M. T., Barrio, G., González‐Sáiz, F., Bravo, M. J., de la Fuente, L., & Itinere Investigators (2010) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-8-145 · Cited by 43
Teoh, J. B. F., Yee, A. H. A., Danaee, M., Ng, C. G., & Sulaiman, A. H. B. (2016) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000267 · Cited by 41
Franklyn, A. M., Eibl, J. K., Gauthier, G., Pellegrini, D., Lightfoot, N. E., & Marsh, D. C. (2017) · Harm Reduction Journal · doi:10.1186/s12954-017-0134-5 · Cited by 39
“One theory is that there is an increased prevalence of comorbid mental health issues—including depression, anxiety, and insomnia—among patients enrolled in OAT [35, 36].”
BackgroundHassan, A. N., Howe, A. S., Samokhvalov, A. V., Foll, B. L., & George, T. P. (2017) · American Journal on Addictions · doi:10.1111/ajad.12581 · Cited by 36
Lee, H.-Y., Li, J., Wu, L.-T. T., Wu, J.-S., Yen, C., & Tang, H. (2012) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-7-11 · Cited by 36
Medved, D., Clausen, T., Bukten, A., Bjørnestad, R., & Muller, A. E. (2020) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-020-00311-4 · Cited by 34
McHugh, R. K., Votaw, V. R., Barlow, D. H., Fitzmaurice, G. M., Greenfield, S. F., & Weiss, R. D. (2017) · Contemporary Clinical Trials · doi:10.1016/j.cct.2017.07.006 · Cited by 33
Saunders, E. C., McGovern, M. P., Lambert-Harris, C. A., Meier, A., McLeman, B. M., & Xie, H. (2015) · American Journal on Addictions · doi:10.1111/ajad.12292 · Cited by 33
Zhou, K., Zhuang, G., Zhang, H., Liang, P., Yin, J., Kou, L., Hao, M., & You, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079828 · Cited by 33
Harvey, L. M., Fan, W., Cano, M. Á., Vaughan, E. L., Arbona, C., Essa, S., Sanchez, H. F., & de Dios, M. A. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.01.016 · Cited by 32
Carpentier, P. J., Knapen, L. J. M., van Gogh, M. T., Buitelaar, J. K., & de Jong, C. A. J. (2012) · Journal of Addictive Diseases · doi:10.1080/10550887.2011.642756 · Cited by 32
Self-citationPsychiatric comorbidity in injecting drug users in Asia and Africa
Iskandar, S., Kamal, R. M., & de Jong, C. A. J. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3283523d66 · Cited by 31
Iskandar, S., van Crevel, R., Hidayat, T., Siregar, I. M., Achmad, T. H., van der Ven, A. J. A. M., & de Jong, C. A. J. (2013) · American Journal on Addictions · doi:10.1111/j.1521-0391.2013.00334.x · Cited by 30
Pro, G. C., Utter, J., Haberstroh, S., & Baldwin, J. A. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.107952 · Cited by 30
King, V. L., Brooner, R. K., Peirce, J. M., Kolodner, K., & KIDORF, M. S. (2014) · Journal of Dual Diagnosis · doi:10.1080/15504263.2014.906132 · Cited by 30
Tsai, T.-Y., Wang, T., Liu, Y. C., Lee, P.-W., Chang, W. H., Lu, T., Tseng, H., Lee, S.-Y., Chang, Y.-H., Yang, Y., et al. (2021) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2020.1849247 · Cited by 29
the ITINERE Project Group, Chahua, M., Niubo, A. S., Torrens, M., Sordo, L., Bravo, M. J., Brugal, M. T., & Domingo‐Salvany, A. (2015) · Quality of Life Research · doi:10.1007/s11136-015-0943-5 · Cited by 28
Hser, Y., Zhu, Y., Fei, Z., Mooney, L. J., Evans, E., Kelleghan, A. R., Matthews, A. G., Yoo, C. K., & Saxon, A. J. (2021) · Addiction · doi:10.1111/add.15594 · Cited by 28
Ashrafioun, L., Zerbo, K. R., Bishop, T. M., & Britton, P. C. (2019) · Psychological Medicine · doi:10.1017/s0033291719002307 · Cited by 27
Fan, C., Tan, H. K.-L., Chien, I., & Chou, S. (2013) · American Journal on Addictions · doi:10.1111/j.1521-0391.2014.12090.x · Cited by 26
Streck, J. M., Ochalek, T. A., Badger, G. J., & Sigmon, S. C. (2018) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000199 · Cited by 26
Kar, H., Gania, A. M., Bandy, A., Dar, N. U. D., & Rafiq, F. (2023) · Scientific Reports · doi:10.1038/s41598-023-45633-y · Cited by 25
Psychological Distress Among Methadone Maintenance Patients in Vietnamese Mountainous Areas
Nguyen, L. H., Tran, B. X., Nguyen, H. L. T., Nguyen, C. T., Hoang, C. D., Le, H. Q., Nguyen, H. V., Le, H. T., Tran, T. D., Latkin, C. A., et al. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1779-5 · Cited by 25
Effects of treatment status and life quality on anxiety in MMT patients
Cao, P., Zhang, Z., Zhong, J., Xu, S., Huang, Q., & Fan, N. (2021) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-021-00343-4 · Cited by 23
Maghsoudi, J., Ghalesefidi, M. J., & Pouragha, B. (2018) · Electronic Journal of General Medicine · doi:10.29333/ejgm/94091 · Cited by 23
Lee, H., Li, J., Sheu, Y.-L., Tang, H., Chang, W., Tang, T., Yeh, Y., Wang, S.-Y., & Liu, R.-H. (2013) · BioMed Research International · doi:10.1155/2013/741403 · Cited by 22
Sanger, N., Panesar, B., Dennis, M. L., Rosic, T., Rodrigues, M., Lovell, E., Yang, S., Butt, M., Thabane, L., & Samaan, Z. (2022) · Patient Related Outcome Measures · doi:10.2147/prom.s297699 · Cited by 22
Khuê, P. M., Vallo, R., Thi, H. D., Hai, O. K. T., Jarlais, D. C. D., Peries, M., Le, S. M., Rapoud, D., Quillet, C., NhamThi, T. T., et al. (2018) · BioMed Research International · doi:10.1155/2018/8346195 · Cited by 21
Chang, L., Chen, Huang, Shan, J., Lin, L., & Chang, W. (2012) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s37284 · Cited by 21
Lund, I. O., Skurtveit, S. O., Sarfi, M., Bakstad, B., Welle-Strand, G. K., & Ravndal, E. (2012) · Journal of Substance Use · doi:10.3109/14659891.2011.642928 · Cited by 20
LaBelle, B., Franklyn, A. M., Nguyen, V. P. K. H., Anderson, K. E., Eibl, J. K., & Marsh, D. C. (2018) · International Journal of Telemedicine and Applications · doi:10.1155/2018/7937610 · Cited by 19
Johansson, R. (2013) · Linköping studies in behavioural science · doi:10.3384/diss.diva-100385 · Cited by 18
Salmabadi, M., Sadeghbojd, M. F., Farshad, M. R., & Zolfaghari, S. (2016) · international journal high risk behaviors & addiction · doi:10.5812/ijhrba.23208 · Cited by 18
Troberg, K., Lundqvist, K., Hansson, H., Håkansson, A., & Dahlman, D. (2022) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-022-00434-w · Cited by 17
Byrne, S. A., Cherniack, M. G., & Petry, N. M. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.01.004 · Cited by 16
Fulton, H. G., Barrett, S. P., MacIsaac, C., & Stewart, S. H. (2011) · Harm Reduction Journal · doi:10.1186/1477-7517-8-18 · Cited by 16
Kamal, R. M., Dijkstra, B. A. G., Oene, G. H. D. W.-V., van Duren, J. A. M., & de Jong, C. A. J. (2016) · Journal of Addictive Diseases · doi:10.1080/10550887.2016.1214000 · Cited by 16
Potik, D., Peles, E., Abramsohn, Y., Adelson, M., & Schreiber, S. (2014) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2014.944290 · Cited by 16
Darke, S. G., Slade, T. N., Ross, J. E., Marel, C., Mills, K. L., & Teesson, M. (2015) · Addictive Behaviors · doi:10.1016/j.addbeh.2015.06.030 · Cited by 16
Quality of life among people who use drugs living in poor urban communities in the Philippines
Yamada, C., Tsutsumi, A., Izutsu, T., Tuliao, M. T. R., Matsuo, H., & Tanaka, E. (2021) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2021.103160 · Cited by 15
Does the Diagnosis of Multiple Axis Ii Disorders Have Clinical Significance?
Zimmerman, M., Galione, J. N., Chelminski, I., Young, D., Dalrymple, K., & Morgan, T. A. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400303 · Cited by 14
Ge, S., Chang, C., Adler, J. R., Zhao, H., Chang, X., Gao, L., Wu, H., Wang, J., Li, N., Wang, X., et al. (2012) · Stereotactic and Functional Neurosurgery · doi:10.1159/000343199 · Cited by 14
Leung, K., Xu, E., Rosic, T., Worster, A., Thabane, L., & Samaan, Z. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03489-4 · Cited by 13
Armoon, B., Bayat, A.-H., Bayani, A., Mohammadi, R., Ahounbar, E., & Fakhri, Y. (2022) · Journal of Substance Use · doi:10.1080/14659891.2022.2069612 · Cited by 12
Nardi, W. R., Kelly, P., Roy, A., Becker, S., Brewer, J., & Sun, S. (2024) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2024.209442 · Cited by 11
Kleinman, M. B., Anvari, M. S., Seitz‐Brown, C. J., Bradley, V. D., Tralka, H. M., Felton, J. W., Belcher, A. M., Greenblatt, A. D., & Magidson, J. F. (2023) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2023.209046 · Cited by 11
Farooqui, A. M., Arya, A., Singh, A. K., & Dalal, P. (2022) · Addiction and Health · doi:10.34172/ahj.2022.1310 · Cited by 11
Lagzi, N., Bateni, A., Goli, R., & Talebiazar, N. (2023) · The International Journal of Psychiatry in Medicine · doi:10.1177/00912174231179320 · Cited by 11
Bråbäck, M., Brådvik, L., Troberg, K., Isendahl, P., Nilsson, S., & Håkansson, A. (2018) · Journal of Addiction · doi:10.1155/2018/3025683 · Cited by 10
Nkyi, A. K., & Ninnoni, J. P. (2020) · Journal of Psychosocial Rehabilitation and Mental Health · doi:10.1007/s40737-020-00190-9 · Cited by 10
Pro, G. C., Giano, Z. D., Camplain, R. L., Haberstroh, S., Camplain, C., Wheeler, D., Hubach, R. D., & Baldwin, J. A. (2020) · Community Mental Health Journal · doi:10.1007/s10597-020-00719-z · Cited by 10
Moses, T. E. H., Rhodes, G. L., Tavakoli, E., CHRISTENSEN, C. W., Amirsadri, A., & Greenwald, M. K. (2022) · Substance Abuse Research and Treatment · doi:10.1177/11782218221138335 · Cited by 9
Alizadehgoradel, J. (2021) · international journal high risk behaviors & addiction · doi:10.5812/ijhrba.100909 · Cited by 9
The Netherlands drug situation 2009
van Laar, M., Cruts, G. A. A. N., van Ooyen-Houben, M., Croes, E., van der Pol, P., Meijer, R. F., & Ketelaars, T. (2010) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 9
Tran, L. T., McKetin, R., Clark, B., Macdonald, C., Zahra, E., Arunogiri, S., Montebello, M. E., & Degenhardt, L. J. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112768 · Cited by 8
Luo, C., Sanger, N., Zielinski, L., Bhatt, M., Shahid, H., Shams, I., Mouravska, N., Luetam, S., Hudson, J., Thabane, L., et al. (2019) · Harm Reduction Journal · doi:10.1186/s12954-019-0283-9 · Cited by 8
Silbernagl, M., Yanagida, T., Slamanig, R., Fischer, G., & Brandt, L. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2019.1590672 · Cited by 8
Meyer, M., Gygli, F., Westenberg, J. N., Schmid, O., Strasser, J., Lang, U. E., Dürsteler, K. M., & Vogel, M. (2023) · Addiction Science & Clinical Practice · doi:10.1186/s13722-023-00397-8 · Cited by 8
Ravndal, E., & Lauritzen, G. (2015) · Nordic Studies on Alcohol and Drugs · doi:10.1515/nsad-2015-0048 · Cited by 8
Kleinman, M. B., Hines, A. C., Anvari, M. S., Bradley, V. D., Shields, A., Dean, D., Abidogun, T. M., Jack, H. E., & Magidson, J. F. (2023) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2023.104234 · Cited by 7
Comorbid Psychopathology and Alcohol Use Patterns among Methadone Maintenance Treatment Patients
Moussas, G., Fanouraki, I., Pachi, A., Asomatou, A., Drylli, O., Paschalakis, G., Tselebis, A., Giotakis, K., Bratis, D., Dermatis, G., et al. (2015) · Journal of Addiction · doi:10.1155/2015/197652 · Cited by 7
Dunn, K. E., King, V. L., & Brooner, R. K. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.01.016 · Cited by 7
Cooperman, N. A., Lu, S., Richter, K. P., Bernstein, S. L., & Williams, J. M. (2016) · Journal of Dual Diagnosis · doi:10.1080/15504263.2016.1172896 · Cited by 7
Soyka, M., Koller, G., Hans-Ulrich, W., & Bühringer, G. (2025) · American Journal on Addictions · doi:10.1111/ajad.70085 · Cited by 6
Ho, Y.-F., Ng, M., Tsai, C.-C., Lee, C.-H., Tsai, D., Chou, J., Huang, C., Shao, W., Lin, T., Chen, V. C., et al. (2016) · Journal of Substance Use · doi:10.3109/14659891.2015.1021866 · Cited by 6
Nikolova, Y. S., Ruocco, A. C., Felsky, D., Lange, S., Prévot, T. D., Vieira, É. L. M., Voineskos, D., Wardell, J. D., Blumberger, D. M., Clifford, K. P., et al. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1455968 · Cited by 6
Le, S. M., Trouiller, P., Duong, T. H., Khuat, T. H. O., Khuê, P. M., Vallo, R., Rapoud, D., Quillet, C., Nguyen, T. L., Nguyen, Q. D., et al. (2021) · Drug and Alcohol Review · doi:10.1111/dar.13402 · Cited by 6
Factors that impact opioid agonist therapy in Northern and Rural Ontario
Franklyn, A. M. (2016) · Lu Zone Ul (Laurentian University) · Cited by 6
Li, Y., Niemelä, S., & Denissoff, A. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00642-x · Cited by 5
Managing Opioid Use Disorder and Co-Occurring Posttraumatic Stress Disorder Among Veterans
Snow, R. D., & Wynn, S. T. (2018) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20180212-03 · Cited by 5
Medication Treatments for Opioid Use Disorder: What Is the Impact on Mood and Mood Disorders?
Hassan, A. N., & Nunes, E. V. (2018) · Current Addiction Reports · doi:10.1007/s40429-018-0215-x · Cited by 5
Metadata
- Authors
- Carpentier, P. J., Krabbe, P. F. M., Van Gogh, M. T., Knapen, L. J. M., Buitelaar, J. K., & De Jong, C. A. J.
- Affiliations
- Reinier van Arkel (NL)
- Radboud University Medical Center (NL)
- Corresponding author
- Carpentier, Pieter J.
- Venue
- The American Journal on Addictions
- Publisher
- Wiley
- Published
- 2009-11-12
- Volume
- 18
- Issue
- 6
- Pages
- 470-480
- ISSN
- 1055-0496 (ISSN-L)
- 1521-0391
- OpenAlex
- W2153248065
- Cited by
- 138
- References
- 75
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 6 · 2023: 5 · 2022: 7 · 2021: 14 · 2020: 6 · 2019: 8 · 2018: 7 · 2017: 6 · 2016: 12 · 2015: 11 · 2014: 10 · 2013: 15 · 2012: 11
- FWCI
- 7.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal on Addictions (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- methadone maintenance treatment, opioid use disorder, psychiatric comorbidity, quality of life, mood disorders, anxiety disorders, personality disorders, antisocial personality disorder, substance use disorders, mental health services
- MeSH terms
- Adult, Antisocial Personality Disorder, Anxiety Disorders, Mental Disorders, Cross-Sectional Studies, Female, Heroin Dependence, Humans, Long-Term Care, Male, Methadone, Middle Aged, Narcotics, Netherlands, Patient Care Team, Quality of Life, Somatoform Disorders, Illicit Drugs, Comorbidity, Mood Disorders, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.